BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Editas Medicine Inc. (NASDAQ:EDIT)

2 posts

Biotech NewsEditas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore

  • BioTech Health X
  • August 13, 2025
Editas Medicine Inc. (NASDAQ:EDIT) is a pioneering gene editing company dedicated to translating the revolutionary potential of CRISPR/Cas12a…
0 Shares
0
0
0
0
0
0
0

Biotech NewsEditas Medicine (EDIT) is a Top Gene Editing Stock to Watch in 2025

  • BioTech Health X
  • May 27, 2025
Editas Medicine Inc. (NASDAQ:EDIT) is a clinical-stage biotechnology firm leading the charge in the development of CRISPR-based gene…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Evoke Pharma (EVOK) Faces Harsh Reality—Can it Avoid Collapse?
  • BBIO Stock Alert: Can BridgeBio Pharma Survive Its Cash Burn?
  • Kala Pharma (KALA) Faces Make-or-Break 2025—Will It Survive?
  • Edgewise Therapeutics (EWTX) Warning: Is This Headed for a Collapse?
  • Mind Medicine (MNMD) Price Target Raised – Analysts See 700% Upside
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 24, 2025
    Evoke Pharma (EVOK) Faces Harsh Reality—Can it Avoid Collapse?
    • August 24, 2025
    BBIO Stock Alert: Can BridgeBio Pharma Survive Its Cash Burn?
    • August 24, 2025
    Kala Pharma (KALA) Faces Make-or-Break 2025—Will It Survive?
    • August 24, 2025
    Edgewise Therapeutics (EWTX) Warning: Is This Headed for a Collapse?
    Breakthrough in Alzheimers Treatment Biogen and Eisais Leqembi Wins UK Approval
    • August 24, 2025
    Mind Medicine (MNMD) Price Target Raised – Analysts See 700% Upside
Recent Posts
  • Nutex Health (NUTX) Could Crash If Compliance Plan Fails
    • August 24, 2025
  • Corcept Therapeutics (CORT) Crashed Monday – Is This the Start of a Bigger Selloff?
    • August 24, 2025
  • ARS Pharmaceuticals (SPRY)Reports $15.7M Q2 Revenue
    • August 24, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (335)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top